Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 20021997)

1.

Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial.

Stein MB, Ravindran LN, Simon NM, Liebowitz MR, Khan A, Brawman-Mintzer O, Lydiard RB, Pollack MH.

J Clin Psychiatry. 2010 May;71(5):627-31. doi: 10.4088/JCP.08m04949gre. Epub 2009 Dec 15.

PMID:
20021997
2.

An open-label study of levetiracetam for the treatment of social anxiety disorder.

Simon NM, Worthington JJ, Doyle AC, Hoge EA, Kinrys G, Fischmann D, Link N, Pollack MH.

J Clin Psychiatry. 2004 Sep;65(9):1219-22.

PMID:
15367048
3.

Levetiracetam in social phobia: a placebo controlled pilot study.

Zhang W, Connor KM, Davidson JR.

J Psychopharmacol. 2005 Sep;19(5):551-3.

PMID:
16166192
4.
5.
6.

A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.

Adams JB, Pyke RE, Costa J, Cutler NR, Schweizer E, Wilcox CS, Wisselink PG, Greiner M, Pierce MW, Pande AC.

J Clin Psychopharmacol. 1995 Dec;15(6):428-34.

PMID:
8748432
7.

Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study.

Asakura S, Tajima O, Koyama T.

Int J Neuropsychopharmacol. 2007 Apr;10(2):263-74. Epub 2006 Mar 30.

PMID:
16573847
9.

Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.

Llorca PM, Spadone C, Sol O, Danniau A, Bougerol T, Corruble E, Faruch M, Macher JP, Sermet E, Servant D.

J Clin Psychiatry. 2002 Nov;63(11):1020-7.

PMID:
12444816
10.

Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.

Stein MB, Pollack MH, Bystritsky A, Kelsey JE, Mangano RM.

Psychopharmacology (Berl). 2005 Jan;177(3):280-8. Epub 2004 Jul 16.

PMID:
15258718
11.

The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.

Hedges DW, Brown BL, Shwalb DA, Godfrey K, Larcher AM.

J Psychopharmacol. 2007 Jan;21(1):102-11. Epub 2006 May 19.

PMID:
16714326
12.

A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.

Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.

J Clin Psychopharmacol. 1993 Dec;13(6):429-37.

PMID:
7907097
13.

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.

Wagner KD, Berard R, Stein MB, Wetherhold E, Carpenter DJ, Perera P, Gee M, Davy K, Machin A.

Arch Gen Psychiatry. 2004 Nov;61(11):1153-62.

PMID:
15520363
14.

Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.

Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J; Deramciclane Dose-Finding Study Group.

Eur Neuropsychopharmacol. 2005 Dec;15(6):617-23. Epub 2005 Jun 9.

PMID:
15949921
15.

Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.

Schutters SI, Van Megen HJ, Van Veen JF, Denys DA, Westenberg HG.

Int Clin Psychopharmacol. 2010 Sep;25(5):302-4.

PMID:
20715300
16.

Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.

Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B.

Am J Psychiatry. 1999 May;156(5):756-60.

PMID:
10327910
17.

A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.

Liebowitz MR, Stein MB, Tancer M, Carpenter D, Oakes R, Pitts CD.

J Clin Psychiatry. 2002 Jan;63(1):66-74.

PMID:
11838629
18.

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.

Int Clin Psychopharmacol. 2006 Nov;21(6):363-7.

PMID:
17012983
19.

A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.

Liebowitz MR, Mangano RM, Bradwejn J, Asnis G; SAD Study Group.

J Clin Psychiatry. 2005 Feb;66(2):238-47.

PMID:
15705011
20.

Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder.

Stein DJ, Cameron A, Amrein R, Montgomery SA; Moclobemide Social Phobia Clinical Study Group.

Int Clin Psychopharmacol. 2002 Jul;17(4):161-70.

PMID:
12131599
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk